uric acid has been researched along with Nephritis, Interstitial in 56 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Nephritis, Interstitial: Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the association between baseline uric acid and the primary composite outcome of doubling of interstitium or ESRD from interstitial fibrosis and tubular atrophy (IF/TA) in the Angiotensin II Blockade for Chronic Allograft Nephropathy (ABCAN) Trial participants." | 9.19 | Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. ( Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R, 2014) |
| "To identify the risk factors of kidney injuries in hypertensive patients with uric acid (UA) metabolic disorders in order to choose the optimal management tactics, by analyzing the changes in markers for endothelial dysfunction (endothelin-1 (ET-1), microalbuminuria (MAU), intima-media thickness (IMT)) and tubulointerstitial tissue lesion (beta2-microglobulin (beta2-MG, monocyte chemotactic protein-1 (MCP-1))." | 7.80 | [Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorder ( Balkarov, IM; Kozlovskaia, LV; Shcherbak, AV; Stakhova, TIu; Taranova, MV, 2014) |
| "We describe three patients in whom severe, life-threatening hyperkalemia and renal insufficiency developed after treatment of acute gouty arthritis with indomethacin." | 7.66 | Indomethacin-induced hyperkalemia in three patients with gouty arthritis. ( Beckstrom, D; Findling, JW; Itskovitz, H; Kozin, F; Rawsthorne, L, 1980) |
| "We evaluated the association between baseline uric acid and the primary composite outcome of doubling of interstitium or ESRD from interstitial fibrosis and tubular atrophy (IF/TA) in the Angiotensin II Blockade for Chronic Allograft Nephropathy (ABCAN) Trial participants." | 5.19 | Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. ( Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R, 2014) |
| "Plasma uric acid levels indicate tubular interstitial lesions in IgAN and hyperuricemia may be considered as a marker for tubulointerstitial lesions." | 3.80 | Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy. ( Chen, Y; Li, X; Liu, Y; Shi, S; Wang, S; Zhang, H; Zhou, J, 2014) |
| "To identify the risk factors of kidney injuries in hypertensive patients with uric acid (UA) metabolic disorders in order to choose the optimal management tactics, by analyzing the changes in markers for endothelial dysfunction (endothelin-1 (ET-1), microalbuminuria (MAU), intima-media thickness (IMT)) and tubulointerstitial tissue lesion (beta2-microglobulin (beta2-MG, monocyte chemotactic protein-1 (MCP-1))." | 3.80 | [Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorder ( Balkarov, IM; Kozlovskaia, LV; Shcherbak, AV; Stakhova, TIu; Taranova, MV, 2014) |
| "At the same glomerular filtration rate (GFR), there was no significant difference in the levels of 24 hours proteinuria, blood urea nitrogen (BUN), and serum creatinine between the two groups with different levels of serum uric acid (p > 0." | 3.79 | Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up. ( Cheng, GY; Liu, DW; Liu, ZS; Tang, L; Zhang, N; Zhao, ZZ, 2013) |
| "To develop a diagnostic questionnaire to identify individuals with uric acid hyperproduction and risk of urate tubulointerstitial nephritis (UTIN)." | 3.70 | [Detection of urate tubulointerstitial nephritis: contribution of diagnostic questionnaire]. ( Balkarov, IM, 1999) |
| "Interstitial nephritis consequent to rifampin was associated with potassium wasting, an acidifying defect, high fractional uric acid excretion, and glucosuria, indicating a multiplicity of renal tubular transport abnormalities." | 3.67 | Potassium wasting and other renal tubular defects with rifampin nephrotoxicity. ( Cheng, JT; Kahn, T, 1984) |
| "We describe three patients in whom severe, life-threatening hyperkalemia and renal insufficiency developed after treatment of acute gouty arthritis with indomethacin." | 3.66 | Indomethacin-induced hyperkalemia in three patients with gouty arthritis. ( Beckstrom, D; Findling, JW; Itskovitz, H; Kozin, F; Rawsthorne, L, 1980) |
| "Hyperuricemia is a specific risk factor for cardiovascular morbidity and mortality." | 2.47 | [Hyperuricemia and uro-nephrological disorders]. ( Hurtes, X; Meria, P, 2011) |
| "Hyperuricemia is an independent risk factor for causing chronic kidney disease and contributes to kidney fibrosis." | 1.46 | High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway. ( He, T; Huang, Y; Li, Y; Liu, H; Xiao, T; Xiong, J; Xu, X; Yu, Y; Zhang, B; Zhang, J; Zhao, J, 2017) |
| " The effects of casein or soya protein combined with palm or safflower-seed oil on various serum parameters and renal histology were investigated on hyperuricaemic rats." | 1.36 | Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats. ( Chiou, HY; Lai, SH; Lo, HC; Wang, YH; Yang, Y, 2010) |
| "The proteinuria was detected at age 10 and 6 years, respectively." | 1.28 | Underexcretory-type hyperuricemia, disproportionate to the reduced glomerular filtration rate, in two boys with mild proteinuria. ( Jojima, K; Kawakami, H; Matsuzaki, H; Murakami, T; Nakatsuka, K; Nohno, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (55.36) | 18.7374 |
| 1990's | 11 (19.64) | 18.2507 |
| 2000's | 4 (7.14) | 29.6817 |
| 2010's | 10 (17.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Xiong, J | 1 |
| He, T | 1 |
| Xiao, T | 1 |
| Li, Y | 1 |
| Yu, Y | 1 |
| Huang, Y | 2 |
| Xu, X | 1 |
| Zhang, J | 1 |
| Zhang, B | 1 |
| Zhao, J | 1 |
| Zhou, J | 1 |
| Chen, Y | 1 |
| Liu, Y | 1 |
| Shi, S | 1 |
| Li, X | 1 |
| Wang, S | 1 |
| Zhang, H | 1 |
| Hart, A | 1 |
| Jackson, S | 1 |
| Kasiske, BL | 1 |
| Mauer, MS | 1 |
| Najafian, B | 1 |
| Matas, AJ | 1 |
| Spong, R | 1 |
| Ibrahim, HN | 1 |
| Stakhova, TIu | 2 |
| Shcherbak, AV | 1 |
| Kozlovskaia, LV | 1 |
| Taranova, MV | 1 |
| Balkarov, IM | 5 |
| Preitner, F | 1 |
| Bonny, O | 1 |
| Laverrière, A | 1 |
| Rotman, S | 1 |
| Firsov, D | 1 |
| Da Costa, A | 1 |
| Metref, S | 1 |
| Thorens, B | 1 |
| Lo, HC | 1 |
| Wang, YH | 1 |
| Chiou, HY | 1 |
| Lai, SH | 1 |
| Yang, Y | 1 |
| Yan, MT | 1 |
| Cheng, CJ | 1 |
| Chen, JS | 1 |
| Lin, SH | 1 |
| Lebedeva, MV | 3 |
| Zaĭtseva, LI | 1 |
| Selivanova, OIu | 1 |
| Severova, MM | 1 |
| Hurtes, X | 1 |
| Meria, P | 1 |
| Bollée, G | 1 |
| Dahan, K | 1 |
| Flamant, M | 1 |
| Morinière, V | 1 |
| Pawtowski, A | 1 |
| Heidet, L | 1 |
| Lacombe, D | 1 |
| Devuyst, O | 1 |
| Pirson, Y | 1 |
| Antignac, C | 1 |
| Knebelmann, B | 1 |
| Cheng, GY | 1 |
| Liu, DW | 1 |
| Zhang, N | 1 |
| Tang, L | 1 |
| Zhao, ZZ | 1 |
| Liu, ZS | 1 |
| Serafini-Cessi, F | 1 |
| Malagolini, N | 1 |
| Cavallone, D | 1 |
| Cameron, MA | 1 |
| Baker, LA | 1 |
| Maalouf, NM | 1 |
| Moe, OW | 1 |
| Sakhaee, K | 1 |
| Marie, J | 1 |
| Royer, P | 1 |
| Rappaport, R | 1 |
| Guyon, B | 1 |
| Ory, JP | 1 |
| Delacour, JL | 1 |
| Wagschal, G | 1 |
| Daoudal, P | 1 |
| Siniachenko, OV | 1 |
| Diadyk, AI | 1 |
| Vasilenko, IV | 1 |
| Cheng, JT | 1 |
| Kahn, T | 1 |
| Boelaert, J | 1 |
| Daneels, R | 1 |
| Schurgers, M | 1 |
| Verschueren, LJ | 1 |
| Amery, A | 1 |
| Arkhipov, VE | 1 |
| Borisov, IA | 1 |
| Nasonov, EL | 1 |
| Sura, VV | 2 |
| Berni, G | 1 |
| Lagi, A | 1 |
| Francois, C | 1 |
| Schollmeyer, P | 1 |
| Lombardo, JV | 1 |
| Terlinsky, A | 1 |
| Chester, AC | 1 |
| Preuss, HG | 1 |
| Findling, JW | 1 |
| Beckstrom, D | 1 |
| Rawsthorne, L | 1 |
| Kozin, F | 1 |
| Itskovitz, H | 1 |
| Parra, E | 1 |
| Gota, R | 1 |
| Gamen, A | 1 |
| Moros, M | 1 |
| Azuara, M | 1 |
| Stabellini, N | 1 |
| Storari, A | 1 |
| Aleotti, A | 1 |
| Fiocchi, O | 1 |
| Tarroni, G | 1 |
| Fabbian, F | 1 |
| Gilli, P | 1 |
| Wrenger, E | 1 |
| Bahlmann, J | 1 |
| Floege, J | 1 |
| Mukhin, NA | 2 |
| Britov, AN | 1 |
| Eliseeva, NA | 1 |
| Bugaeva, NV | 1 |
| Kozlova, VG | 1 |
| Degtiarev, VA | 1 |
| Shonichev, DG | 2 |
| Paramonov, AD | 1 |
| Futrakul, P | 1 |
| Yenrudi, S | 1 |
| Futrakul, N | 1 |
| Sensirivatana, R | 1 |
| Kingwatanakul, P | 1 |
| Jungthirapanich, J | 1 |
| Cherdkiadtikul, T | 1 |
| Laohapaibul, A | 1 |
| Watana, D | 1 |
| Singkhwa, V | 1 |
| Futrakul, S | 1 |
| Pongsin, P | 1 |
| Iino, Y | 1 |
| Cameron, JS | 1 |
| Simmonds, HA | 1 |
| Morin, C | 1 |
| Bernier, J | 1 |
| Bluestone, R | 3 |
| Waisman, J | 3 |
| Klinenberg, JR | 3 |
| Mwasi, LM | 1 |
| Ishkabulov, DI | 1 |
| Tukhvatulina, RR | 1 |
| Akhmatov, A | 1 |
| Abdurakhmanova, SK | 1 |
| Hillebrand, G | 1 |
| Reiter, S | 1 |
| Murakami, T | 1 |
| Kawakami, H | 1 |
| Nakatsuka, K | 1 |
| Jojima, K | 1 |
| Nohno, H | 1 |
| Matsuzaki, H | 1 |
| Shirai, J | 1 |
| Nakamura, K | 1 |
| Narita, M | 1 |
| Furuta, K | 1 |
| Hihara, H | 1 |
| Kawamura, H | 1 |
| Erley, CM | 1 |
| Hirschberg, RR | 1 |
| Hoefer, W | 1 |
| Schaefer, K | 1 |
| Benabe, JE | 1 |
| Martínez-Maldonado, M | 1 |
| Dykman, D | 1 |
| Simon, EE | 1 |
| Rundles, RW | 1 |
| Puschett, JB | 1 |
| Dotchev, D | 1 |
| Hungerland, H | 1 |
| Liappis, N | 1 |
| Oyanagi, K | 1 |
| Delbarre, F | 1 |
| de Gery, A | 1 |
| Hall, PW | 1 |
| Piscator, M | 1 |
| Vasiljević, M | 1 |
| Popović, N | 1 |
| Stein, G | 1 |
| Kagami, T | 1 |
| Lagrue, G | 2 |
| Ménard, J | 2 |
| Safar, M | 1 |
| Schlotterer, P | 1 |
| Milliez, P | 1 |
| Louyot, P | 1 |
| Gaucher, A | 1 |
| Benoit, P | 1 |
| Ginsbourger, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Value of Uric Acid as Early Predictor of Lupus Nephritis in Assiut University Hospital[NCT05402735] | 100 participants (Anticipated) | Observational | 2022-06-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for uric acid and Nephritis, Interstitial
| Article | Year |
|---|---|
[Hyperuricemia and uro-nephrological disorders].
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diagnosis, Differential; Humans; Hypertension; H | 2011 |
Tamm-Horsfall glycoprotein: biology and clinical relevance.
Topics: Escherichia coli; Humans; Mucoproteins; Mutation; Nephritis, Interstitial; Protein Binding; Structur | 2003 |
[Renal failure caused by non-steroid anti-inflammatory agents].
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Drug Interactions; Glomerulonephritis; Humans; Hy | 1983 |
[Hyperuricemia, gout and gout-induced nephropathy].
Topics: Allopurinol; Female; Gout; Humans; Kidney Calculi; Male; Nephritis, Interstitial; Purines; Uric Acid | 1980 |
[Urate nephropathy].
Topics: Allopurinol; Gout; Humans; Kidney Calculi; Kidney Diseases; Nephritis, Interstitial; Purines; Uric A | 1981 |
[Uric acid and tubulointerstitial kidney diseases].
Topics: Gout; Humans; Kidney Function Tests; Nephritis, Interstitial; Renal Dialysis; Uric Acid | 1996 |
[Development of arterial hypertension in urate tubulointerstitial renal damage].
Topics: Acetylglucosaminidase; Adolescent; Adult; Biomarkers; Biopsy; Blood Pressure; Cytokines; Female; Hum | 1999 |
[Metabolic tubulo-interstitial nephropathies].
Topics: Cystinuria; Humans; Metabolic Diseases; Nephritis, Interstitial; Oxalates; Uric Acid | 1999 |
[Gout crisis].
Topics: Adult; Aged; Diagnosis, Differential; Gout; Humans; Male; Middle Aged; Nephritis, Interstitial; Uric | 2000 |
[The kidney and uric acid].
Topics: Acute Kidney Injury; Female; Gout; Humans; Hypertension; Kidney; Kidney Calculi; Kidney Diseases; Ki | 1975 |
Tubulo-interstitial nephritis associated with systemic disease and electrolyte abnormalities.
Topics: Chronic Disease; Gout; Humans; Multiple Myeloma; Nephritis, Interstitial; Sarcoidosis; Sjogren's Syn | 1988 |
[Gout, archetype of diseases caused by deposits].
Topics: Gout; Humans; Kidney Calculi; Kinins; Lesch-Nyhan Syndrome; Metabolic Diseases; Nephritis, Interstit | 1972 |
2 trials available for uric acid and Nephritis, Interstitial
| Article | Year |
|---|---|
Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
Topics: Allografts; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Chronic Diseas | 2014 |
[Antihypertensive therapy optimization and endothelial function in patients with gout and chronic urate tubulointerstitial nephritis].
Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2010 |
42 other studies available for uric acid and Nephritis, Interstitial
| Article | Year |
|---|---|
High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway.
Topics: Actins; Antigens, CD; Biomarkers; Cadherins; Cell Line; Cytokines; Epithelial Cells; Epithelial-Mese | 2017 |
Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy.
Topics: Adult; Biomarkers; Early Diagnosis; Female; Glomerulonephritis, IGA; Humans; Hyperuricemia; Male; Ne | 2014 |
[Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorder
Topics: Albuminuria; beta 2-Microglobulin; Biomarkers; Chemokine CCL2; Comorbidity; Endothelin-1; Endotheliu | 2014 |
Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.
Topics: Analysis of Variance; Animals; Blotting, Western; Glucose Transport Proteins, Facilitative; Hepatocy | 2009 |
Relative efficacy of casein or soya protein combined with palm or safflower-seed oil on hyperuricaemia in rats.
Topics: Albumins; Analysis of Variance; Animals; Blood Urea Nitrogen; Caseins; Cholesterol; Creatinine; Diet | 2010 |
The case: a young man with acute kidney injury after exercise. The diagnosis: exercise induced acute kidney injury in hereditary renal hypouricemia.
Topics: Acute Kidney Injury; Creatinine; Exercise; Follow-Up Studies; Humans; Nephritis, Interstitial; Renal | 2010 |
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.
Topics: Adult; Belgium; Biomarkers; Central Nervous System Diseases; Chi-Square Distribution; Dental Enamel; | 2011 |
Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
Topics: Adult; Blood Urea Nitrogen; Confidence Intervals; Creatinine; Follow-Up Studies; Glomerular Filtrati | 2013 |
Circadian variation in urine pH and uric acid nephrolithiasis risk.
Topics: Adolescent; Circadian Rhythm; Glucose; Humans; Hydrogen-Ion Concentration; Insulin Resistance; Male; | 2007 |
[Congenital hyperuricemia with neurologic, renal and blood disturbances].
Topics: Adolescent; Allopurinol; Anemia, Macrocytic; Athetosis; Chorea; Gout; Humans; Intellectual Disabilit | 1967 |
[Gouty nephropathy (a review of the literature)].
Topics: Animals; Gout; Humans; Kidney; Kidney Calculi; Kidney Diseases; Nephritis, Interstitial; Purines; Ra | 1984 |
Potassium wasting and other renal tubular defects with rifampin nephrotoxicity.
Topics: Adult; Anti-Bacterial Agents; Humans; Hypokalemia; Kidney Tubules; Male; Nephritis, Interstitial; Po | 1984 |
Sulphinpyrazone--induced decrease in renal function: a review of reports with discussion of pathogenesis.
Topics: Acute Kidney Injury; Adult; Aged; Female; Humans; Kallikreins; Kinins; Male; Middle Aged; Nephritis, | 1982 |
[Interstitial nephritis in metabolic diseases].
Topics: Amyloidosis; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperkalemia; Kidney Calculi; Metabo | 1980 |
Tubulointerstitial diseases.
Topics: Analgesics; Drug Hypersensitivity; Glomerular Filtration Rate; Humans; Hypercalcemia; Hypokalemia; I | 1980 |
Indomethacin-induced hyperkalemia in three patients with gouty arthritis.
Topics: Acute Disease; Acute Kidney Injury; Aged; Diabetes Mellitus; Female; Gout; Humans; Hyperkalemia; Ind | 1980 |
Granulomatous interstitial nephritis secondary to allopurinol treatment.
Topics: Allopurinol; Female; Granuloma; Humans; Kidney; Middle Aged; Nephritis, Interstitial; Uric Acid | 1995 |
Familial interstitial nephropathy without hyperuricemia.
Topics: Adult; Aged; Biopsy; Family Health; Female; Fibrosis; Humans; Kidney; Kidney Diseases; Male; Middle | 1994 |
[The population aspects of renal arterial hypertension].
Topics: Adult; Humans; Hypertension, Renal; Nephritis, Interstitial; Nephrosclerosis; Risk Factors; Uric Aci | 1997 |
Tubular function and tubulointerstitial disease.
Topics: Adolescent; Biological Transport; Calcium; Child; Female; Glomerular Mesangium; Glomerulonephritis; | 1999 |
[Detection of urate tubulointerstitial nephritis: contribution of diagnostic questionnaire].
Topics: Adolescent; Adult; Aged; Disease Progression; Disease Susceptibility; Female; Humans; Male; Middle A | 1999 |
Gout and crystal-related nephropathy.
Topics: Adenine Phosphoribosyltransferase; Female; Gout; Humans; Kidney; Kidney Calculi; Kidney Diseases; Le | 1979 |
The gouty kidney.
Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Gout; Humans; Kidney; Kidney C | 1977 |
Chronic experimental hyperuricemic nephropathy.
Topics: Animals; Disease Models, Animal; Gout; Kidney; Kidney Calculi; Nephritis, Interstitial; Oxonic Acid; | 1975 |
Letter: Chronic interstitial nephritis: analgesic "abuse", hyperuricemia.
Topics: Analgesics; Chronic Disease; Female; Headache; Humans; Nephritis, Interstitial; Substance-Related Di | 1975 |
Acute hyperuricemic nephropathy in rats. An electron microscopic study.
Topics: Animals; Disease Models, Animal; Gout; Kidney; Kidney Calculi; Kidney Diseases; Kidney Tubules; Male | 1975 |
[Characteristics of uric acid metabolism and the activity of various enzymes in the families of patients with interstitial nephritis].
Topics: Adult; Alkaline Phosphatase; Child; Circadian Rhythm; Creatine Kinase; Humans; L-Lactate Dehydrogena | 1991 |
[Hypouricemia--a differential diagnostic problem].
Topics: Adult; Creatinine; Diagnosis, Differential; Femur Head Necrosis; Humans; Kidney Function Tests; Male | 1991 |
Underexcretory-type hyperuricemia, disproportionate to the reduced glomerular filtration rate, in two boys with mild proteinuria.
Topics: Child; Creatinine; Glomerular Filtration Rate; Gout; Humans; Kidney; Male; Nephritis, Interstitial; | 1990 |
Visceral urate deposits in chicks inoculated with avian nephritis virus.
Topics: Analysis of Variance; Animals; Chickens; Kidney; Nephritis, Interstitial; Picornaviridae; Picornavir | 1989 |
Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia.
Topics: Acute Kidney Injury; Adult; Creatinine; Humans; Kidney Function Tests; Kidney Tubules; Male; Nephrit | 1989 |
Hyperuricemia and uric acid nephropathy.
Topics: Aged; Allopurinol; Female; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Nephritis, Inters | 1987 |
The development of allopurinol.
Topics: Allopurinol; Animals; Chemistry; Coronary Disease; Gout; History, 20th Century; Humans; Hypertension | 1985 |
Diuretic therapy update.
Topics: Acid-Base Imbalance; Acute Kidney Injury; Diet, Sodium-Restricted; Diuretics; Ear Diseases; Heart Fa | 1985 |
[Hyperiminoaciduria and disaminoaciduria in endemic (Balkan-)nephropathy (author's transl)].
Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Thin Layer; Chronic Disease; Creatinine; Female; | 1974 |
Medical Grand Rounds from the University of Alabama Medical Center. Lead poisoning.
Topics: Adult; Aged; Alcoholism; Amyotrophic Lateral Sclerosis; Anemia, Macrocytic; Brain Diseases; Diagnosi | 1972 |
Renal function studies in indivuals with the tubular proteinuria of endemic Balkan nephropathy.
Topics: Ammonia; Bicarbonates; Creatinine; Electrophoresis; Glycosuria; Humans; Hydrogen-Ion Concentration; | 1972 |
[Kidney involvement in gout].
Topics: Adolescent; Adult; Aged; Allopurinol; Anti-Bacterial Agents; Antihypertensive Agents; Female; Gout; | 1972 |
[Hyperuricemia].
Topics: Gout; Humans; Kidney; Kidney Glomerulus; Kidney Tubules; Microscopy, Electron; Nephritis, Interstiti | 1972 |
[The kidney and hyperuricemia].
Topics: Diuretics; Gout; Humans; Kidney Calculi; Kidney Diseases; Kidney Failure, Chronic; Kidney Function T | 1971 |
[Hyperuricemia due to diuretics in hypertensive patients. Curative treatment with benziodarone].
Topics: Adult; Benzofurans; Diuretics; Female; Humans; Hypertension; Kidney Function Tests; Male; Middle Age | 1971 |
[On a family of persons with severe gout].
Topics: Blood; Female; Gout; Hip Dislocation, Congenital; Humans; Male; Middle Aged; Nephritis, Interstitial | 1965 |